Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.

Lipotoxicity of the heart has been implicated as a leading cause of morbidity in Type 2 Diabetes Mellitus (T2DM). While numerous reports have demonstrated increased myocardial fatty acid (FA) utilization in obese T2DM animal models, this diabetic phenotype has yet to be demonstrated in non-obese ani...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Sriram Devanathan, Samuel T Nemanich, Attila Kovacs, Nicole Fettig, Robert J Gropler, Kooresh I Shoghi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Online Access:	http://europepmc.org/articles/PMC3804536?pdf=render

Similar Items

An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: functional, metabolic, and differential network analysis.
by: Sriram Devanathan, et al.
Published: (2014-01-01)

Metabolic Disposition and Elimination of Tritum-Labeled Sulfamethoxazole in Pigs, Chickens and Rats
by: Jingchao Guo, et al.
Published: (2022-12-01)

Increased Metabolic Stress in Zucker Diabetic Fatty Rat Kidney and Pancreas
by: Haider Raza, et al.
Published: (2013-12-01)

Detection of early-stage NASH using non-invasive hyperpolarized 13C metabolic imaging
by: Cornelius von Morze, et al.
Published: (2024-06-01)

Cyp3a4-Mediated in vitro Metabolism and in vivo Disposition of Lorlatinib in Rats
by: Xie C, et al.
Published: (2025-10-01)

Fatty acid and carbohydrate metabolism in acute myocardial ischemia
by: M. A. Aripov, et al.
Published: (2005-10-01)

Impact of metabolic enzyme activity variability on dabrafenib disposition
by: Shi-yu Wang, et al.
Published: (2025-09-01)

Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats
by: Brunner V, et al.
Published: (2015-06-01)

The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease
by: Yujuan Zhang, et al.
Published: (2024-02-01)

(+)-Z-Bisdehydrodoisynolic Acid Enhances Basal Metabolism and Fatty Acid Oxidation in Female Obese Zucker Rats
by: William J. Banz, et al.
Published: (2012-01-01)

Effect of electroacupuncture on the intestinal flora-short chain fatty acid metabolism axis in simple obesity rats
by: LIU Xia, et al.
Published: (2024-08-01)

Fatty acid metabolism decreased while sexual selection increased in brown rats spreading south
by: Yao-Hua Zhang, et al.
Published: (2023-10-01)

Obesity and nonalcoholic fatty liver disease: metabolic risks and their correction
by: Kseniya Andreevna Komshilova, et al.
Published: (2015-08-01)

Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism
by: Changpei Gan, et al.
Published: (2023-02-01)

Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats
by: WANG Hai-ying, et al.
Published: (2019-01-01)

Non-alcoholic fatty hepatic disease in children with obesity and metabolic syndrome
by: T. A. Bokova
Published: (2021-06-01)

Circulating Fatty Acids Associate with Metabolic Changes in Adolescents Living with Obesity
by: Branko Subošić, et al.
Published: (2024-04-01)

Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals
by: Yan Ni, et al.
Published: (2015-10-01)

Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome
by: Anders Askeland, et al.
Published: (2025-03-01)

Longitudinal Evaluation of Myocardial Fatty Acid and Glucose Metabolism in Fasted and Nonfasted Spontaneously Hypertensive Rats Using MicroPET/CT
by: Jennifer S. Huber PhD, et al.
Published: (2017-08-01)

Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease
by: Stepan Melnyk, et al.
Published: (2023-08-01)

Resveratrol Supplementation in Obese Pregnant Rats Improves Maternal Metabolism and Prevents Increased Placental Oxidative Stress
by: Guadalupe L. Rodríguez-González, et al.
Published: (2022-09-01)

Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids
by: Júlia T. Novaes, et al.
Published: (2017-10-01)

Ventricular Dysfunction in Obese and Nonobese Rats with Metabolic Syndrome
by: Julian Torres-Jacome, et al.
Published: (2022-01-01)

CHANGE OF MYOCARDIAL GLUCOSE AND FREE FATTY ACID METABOLISM AND EFFECT OF ELECTROACUPUNCTURE ON THEM DURING EXPERIMENTAL MYOCARDIAL ANGINA
by: Gao Cuihua, et al.
Published: (1990-01-01)

ST-segment elevation myocardial infarction in the presence of metabolic-associated fatty liver disease
by: V. A. Tretyakova, et al.
Published: (2023-12-01)

Identification of shared fatty acid metabolism related signatures in dilated cardiomyopathy and myocardial infarction
by: Baoyi Huang, et al.
Published: (2023-03-01)

Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism
by: Yue Lin, et al.
Published: (2024-08-01)

Clinical epidemiology of metabolic-associated fatty liver disease in overweight and obese children
by: O.O. Starets, et al.
Published: (2024-09-01)

Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity
by: Sofia Ferreira, et al.
Published: (2024-02-01)

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
by: Mahamid M, et al.
Published: (2018-09-01)

47149 Imaging Tools for Early Detection of Kidney Disease.
by: Edwin J. Baldelomar, et al.
Published: (2021-03-01)

Flaxseed Polysaccharide Alters Colonic Gene Expression of Lipid Metabolism and Energy Metabolism in Obese Rats
by: Hua Wei, et al.
Published: (2022-07-01)

Predictive Value of the Triglyceride-Glucose Index for Metabolic-Associated Fatty Liver Disease in Individuals with Different Metabolic Obese Phenotypes
by: Lv D, et al.
Published: (2025-01-01)

Correlation of Body Fat Composition and Metabolic Indicators with Metabolic-associated Fatty Liver Disease in a Non-obese Population
by: WANG Yingjie, CHENG Haoran, ZHOU Weihong
Published: (2023-02-01)

Fatty liver in uncomplicated type 2 DM is associated with impaired myocardial HEP metabolism, modulated by myocardial glucose uptake
by: de Roos Albert, et al.
Published: (2009-01-01)

Non-targeted metabolomics reveals myocardial metabolic alterations in epileptic rats
by: Yue Hu, et al.
Published: (2026-01-01)

<b>Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni, et al.
Published: (2018-11-01)

Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
by: Jae Young Yu, et al.
Published: (2018-12-01)

Effects of Hibiscus sabdariffa supplementation on metabolism and bladder in obese rats
by: Pedro Pajolli, et al.
Published: (2024-09-01)